author-photo

Mary Ann Mascelli

Fox Chase Cancer Center

62

Papers

4641

Citations

Citation Trend

Filter By

Papers (39) Sort By

Journal Conference Others

Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations

2019 The Journal of Allergy and Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (38)
Bronchial mucosal IFN-?/? and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations

2018 The Journal of Allergy and Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives

2012 Annals of the New York Academy of Sciences
Show All
- Source
- Cite
- Save
Citations (74)
Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives - an update: Ustekinumab development as psoriasis treatment

2012 Annals of the New York Academy of Sciences
Show All
- Source
- Cite
- Save
Citations (22)
Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab

2011 Nature Biotechnology
Show All
- Source
- Cite
- Save
Citations (113)
Effects of ustekinumab administration on primate/human antigen-recall and humoral immune response functions.

2010 Journal of Drugs in Dermatology
Show All
- Source
- Cite
- Save
Citations (14)
Molecular, biologic, and pharmacokinetic properties of monoclonal antibodies: impact of these parameters on early clinical development.

2007 The Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (85)
A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12/23 monoclonal antibody in subjects with plaque psoriasis

2007 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (96)
Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis

2007 The Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (168)
A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis.

2006 The Journal of Rheumatology
Show All
- Source
- Cite
- Save
Citations (22)